Medicare Enrolled

Dr. Marc Usrey, M.D.

Hematology & Oncology · Tyler, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
721 CLINIC DR, Tyler, TX 75701
9035926152
In practice since 2007 (18 years)
NPI: 1952504045 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Usrey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Usrey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Usrey

Dr. Marc Usrey is a hematology & oncology in Tyler, TX, with 18 years in practice. Based on federal Medicare data, Dr. Usrey performed 987 Medicare services across 587 unique beneficiaries.

Between the years covered by Open Payments, Dr. Usrey received a total of $3,514 from 44 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Usrey is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 50% volume in TX$ $3,514 industry payments

Medicare Practice Summary

Medicare Utilization ↗
987
Medicare services
Top 50% in TX for hematology & oncology
587
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~55 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)319$98$327
Office visit, established patient (30-39 min)265$65$231
Hospital follow-up visit, high complexity107$90$306
Chronic care management, first 20 min/month79$39$95
New patient office visit, complex (60-74 min)68$130$495
Hospital follow-up visit, moderate complexity49$61$212
Office visit, established patient (20-29 min)41$42$150
Chronic care management, additional 20 min/month23$27$141
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional19$5$27
Initial hospital admission, high complexity17$133$595
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,514
Total received (2018-2024)
Avg $502/year across 7 years
Top 49% in TX for hematology & oncology
44
Companies
144
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,366 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$147 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,971
2023
$1,137
2022
$194
2021
$124
2020
$38
2019
$35
2018
$15

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$529
ABBVIE INC.
$312
Pharmacyclics LLC, An AbbVie Company
$245
Genentech USA, Inc.
$195
Lilly USA, LLC
$190
AstraZeneca Pharmaceuticals LP
$173
Novartis Pharmaceuticals Corporation
$146
Tempus AI, Inc
$133
PFIZER INC.
$120
JAZZ PHARMACEUTICALS INC.
$95
GENZYME CORPORATION
$81
Janssen Biotech, Inc.
$78
Regeneron Healthcare Solutions, Inc.
$73
E.R. Squibb & Sons, L.L.C.
$71
Bayer Healthcare Pharmaceuticals Inc.
$68
SOBI, INC
$65
ARRAY BIOPHARMA INC
$64
Takeda Pharmaceuticals U.S.A., Inc.
$63
Gilead Sciences, Inc.
$62
Karyopharm Therapeutics Inc.
$60
Alexion Pharmaceuticals, Inc.
$53
Aveo Pharmaceuticals, Inc.
$51
Eisai Inc.
$45
Stemline Therapeutics Inc.
$42
MorphoSys, US Inc.
$41
GlaxoSmithKline, LLC.
$39
ADC Therapeutics America, Inc.
$35
Celgene Corporation
$34
EMD Serono, Inc.
$32
Dendreon Pharmaceuticals LLC
$31
Genmab U.S., Inc.
$31
BeiGene USA, Inc.
$29
Mirati Therapeutics, Inc.
$25
Sumitomo Pharma America, Inc.
$24
Sun Pharmaceutical Industries Inc.
$23
EAGLE PHARMACEUTICALS, INC.
$23
AbbVie Inc.
$20
TAIHO ONCOLOGY, INC.
$20
AVEO Pharmaceuticals, Inc.
$18
Daiichi Sankyo Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
Astellas Pharma US Inc
$15
Adaptive Biotechnologies Corporation
$14
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 30.9% of total payments
Associated products mentioned in payments ›
ALYMSYS · BRUKINSA · CREON · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ENHERTU · EPKINLY · Epkinly · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · IBRANCE · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · JEMPERLI · Jivi · KISQALI · KRAZATI · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MYRISK · NINLARO · Nubeqa · OJJAARA · OPDIVO · ORGOVYX · Odomzo · Onivyde · Orserdu · PLUVICTO · PROVENGE · Phesgo · Pomalyst · Ryanodex · SARCLISA · SCEMBLIX · Stivarga · TECENTRIQ · TECVAYLI · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Venclexta · XALKORI · XPOVIO · XT CDX · Xtandi · ZEPZELCA · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $356 per 100 Medicare services performed
Looking for a hematology & oncology in Tyler?
Compare hematology & oncologys in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
10
Per 100K population
4.2
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Usrey is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Usrey experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Usrey performed 319 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Usrey receive payments from pharmaceutical companies?
Yes. Dr. Usrey received a total of $3,514 from 44 companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Usrey's costs compare to other hematology & oncologys in Tyler?
Dr. Usrey's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Usrey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →